Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...
Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...
Survival and Growth of Prostate Cancer Cells in the Bone: Role of the Alpha-Receptor for Platelet-Derived Growth Factor in Supporting Early Metastatic FociSkeletal dissemination is by far the most feared complication of prostate cancer and the main cause of patients' demise. Today, 85% of ...
Then, we calculated the overall one-year and five-year survival rates of prostate cancer patients by Kaplan–Meier(KM) curves, and survival differences were examined by the log-rank test. We used a multivariable Cox model to estimate hazard ratio (HR) of cancer according to the survival ...
Effect of denosumab on prolonging bone-metastasis-free survival (BMFS) in men with nonmetastatic castrate-resistant prostate cancer (CRPC) presenting with aggressive PSA kinetics. Smith MR, Saad F, Shore ND et al (2012) Effect of denosumab on prolonging bone-metastasis-free survival (BMFS) in...
Furthermore, the current study investigates whether or not regucalcin plays a suppressive role in bone metastatic human prostate cancer cells. Notably, microarray analysis with patient's datasets demonstrated that progression-free survival of prostate cancer patients was found to be prolonged in patients...
Specifically there is strong evidence that interactions between tumour cells and BMSCs (bone marrow stromal cells) play a major role in supporting prostate cancer growth and survival in bone. Here, we examine factors shown to be secreted by BMSCs, such as IGFs (insulin-like growth factors) ...
WebMD's slideshow covers prostate cancer: who's at risk, symptoms, tests, staging, treatments, survival, and foods that may help lower your risk for prostate cancer.
Hope, MD JAMA Oncology Key Points Question Are bone metastatic burden and site associated with survival benefit from the addition of prostate radiotherapy (RT) to standard-of-care systemic therapy in newly diagnosed metastatic prostate cancer? Findings This exploratory analysis of 1939 participants in ...
it is not then calledbone cancer. It is prostate cancer metastatic to the bones. Metastasisis the process of cancer spread through the blood or lymphatic system to other organs/areas throughout the body. Prostate cancer more commonly metastasizes to lymph nodesin the pelvis and to the bones....